Nonprofit · EIN 13-1933825
CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION
Also known as DAMON RUNYON CANCER RESEARCH FND
Tax-exempt · NEW YORK, NY 10006
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $54,683,607 | $25,059,618 | $29,623,989 | $170,380,475 | $35,526,498 | $134,853,977 |
| June 30, 2024 | 990 | $19,559,693 | $25,408,684 | -$5,848,991 | $160,511,709 | $35,205,374 | $125,306,335 |
| June 30, 2023 | 990 | $15,715,675 | $21,219,216 | -$5,503,541 | $147,680,687 | $32,920,972 | $114,759,715 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $16,245,486
- Program service revenue
- $0
- Investment income
- $37,892,118
- Royalties
- $391,793
- Net gain from sales of assets
- $34,570,409
- Net income from fundraising events
- -$104,554
- Other revenue
- $546,003
Expenses
- Grants and similar amounts paid
- $20,170,035
- Compensation of officers, directors and key employees
- $666,526
- Other salaries and wages
- $1,756,670
- Salaries, compensation and benefits (total)
- $3,063,164
- Professional fundraising fees
- $0
- Legal fees
- $22,829
- Accounting fees
- $229,412
- Occupancy
- $364,829
- Travel
- $149,635
- Depreciation
- $24,196
- Program services (functional)
- $22,291,129
- Management and general (functional)
- $913,716
- Fundraising (functional)
- $1,854,773
Balance sheet and other
- Total assets, start of year
- $160,511,709
- Total assets, end of year
- $170,380,475
- Total liabilities, end of year
- $35,526,498
- Net assets, end of year
- $134,853,977
- Land, buildings and equipment
- $217,597
- Publicly traded securities
- $136,850,784
- Net assets without donor restrictions
- $114,368,896
- Net assets with donor restrictions
- $20,485,081
- Gross receipts
- $177,565,031
- Employees
- 17
- Volunteers
- 200
- Year formed
- 1947
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| YUNG S LIE PHD | PRESIDENT & CEO Officer | 40 | $592,380 | $59,913 |
| CLARE CAHILL | CHIEF ADMINISTRATIVE OFFICER Highest-paid employee | 40 | $253,185 | $36,955 |
| KIMBERLY KUBERT | DIRECTOR OF SPECIAL EVENTS Highest-paid employee | 40 | $211,585 | $35,757 |
| ELYSE HOFFMANN | SENIOR DIRECTOR OF STRATEGIC PARTNERSHIP Highest-paid employee | 40 | $199,837 | $39,199 |
| MEGHAN MCCURDY | DIRECTOR OF COMMUNICATIONS & MARKETING Highest-paid employee | 40 | $157,037 | $43,527 |
| MEGAN ALLEN PHD | SCIENTIFIC DIRECTOR Highest-paid employee | 40 | $143,407 | $24,343 |
| ANDREW S RACHLEFF | CHAIR (AS OF 10/15/24) Trustee or director, Officer | 1 | $0 | $0 |
| DAVID G MARSHALL | VICE CHAIR, INVESTMENTS & TREASURER (THRU 6/10/25) Trustee or director, Officer | 1 | $0 | $0 |
| DAVID M BEIRNE | VICE CHAIR, BOARD DEVELOPMENT Trustee or director, Officer | 1 | $0 | $0 |
| DEBORAH J COLEMAN | SECRETARY (AS OF 6/10/25) Trustee or director, Officer | 1 | $0 | $0 |
| LAURENCE W COHEN | TREASURER (AS OF 10/15/24) Trustee or director, Officer | 1 | $0 | $0 |
| MICHAEL L GORDON | VICE CHAIR, BOARD DEVELOPMENT (THRU 10/15/24) Trustee or director, Officer | 1 | $0 | $0 |
| SANFORD W MORHOUSE ESQ | VICE CHAIR, AUDIT & SECRETARY (THRU 6/10/25) Trustee or director, Officer | 1 | $0 | $0 |
| WILLIAM G KAELIN JR MD | VICE CHAIR, SCIENTIFIC PROGRAMS Trustee or director, Officer | 1 | $0 | $0 |
| ADAM R SCHWARTZ | DIRECTOR Trustee or director | 1 | $0 | $0 |
32 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| AMOOLYA SINGH PHD | DIRECTOR Trustee or director | 1 | $0 |
| BUCK FRENCH | DIRECTOR Trustee or director | 1 | $0 |
| CARLOS L ARTEAGA MD | DIRECTOR Trustee or director | 1 | $0 |
| CYNTHIA SULZBERGER | DIRECTOR Trustee or director | 1 | $0 |
| DAVID A GORDON PHD | DIRECTOR Trustee or director | 1 | $0 |
| ELAINE V FUCHS PHD | DIRECTOR Trustee or director | 1 | $0 |
| ERICA EVANS GIOFFRE | DIRECTOR Trustee or director | 1 | $0 |
| GABRIELLE LAYTON PHD | DIRECTOR Trustee or director | 1 | $0 |
| GARY E ERLBAUM | DIRECTOR Trustee or director | 1 | $0 |
| GERALD M MARSHALL | DIRECTOR Trustee or director | 1 | $0 |
| JAMES WELLS PHD | DIRECTOR Trustee or director | 1 | $0 |
| JOHN H MYERS | DIRECTOR (THRU 10/15/24) Trustee or director | 1 | $0 |
| JOSEPH PEARLBERG MD PHD | DIRECTOR Trustee or director | 1 | $0 |
| JUDY SWANSON | DIRECTOR Trustee or director | 1 | $0 |
| KAREN D SEITZ | DIRECTOR (THRU 10/15/24) Trustee or director | 1 | $0 |
| LEVI A GARRAWAY MD PHD | DIRECTOR Trustee or director | 1 | $0 |
| LORI J PIERCE MD | DIRECTOR Trustee or director | 1 | $0 |
| MELISSA L COHN | DIRECTOR Trustee or director | 1 | $0 |
| MICHAEL V SEIDEN MD PHD | DIRECTOR Trustee or director | 1 | $0 |
| MORANA JOVAN-EMBIRICOS PHD | DIRECTOR Trustee or director | 1 | $0 |
| NANCY SIMONIAN MD | DIRECTOR Trustee or director | 1 | $0 |
| NOAH KNAUF | DIRECTOR Trustee or director | 1 | $0 |
| PETER VAN CAMP | DIRECTOR Trustee or director | 1 | $0 |
| RICHARD B GAYNOR MD | DIRECTOR Trustee or director | 1 | $0 |
| RICHARD HOFFMAN | DIRECTOR Trustee or director | 1 | $0 |
| RICHARD J O'REILLY MD | DIRECTOR Trustee or director | 1 | $0 |
| RICHARD W MEIER | DIRECTOR Trustee or director | 1 | $0 |
| ROBYN COLES | DIRECTOR Trustee or director | 1 | $0 |
| SCOTT GREENSTEIN | DIRECTOR Trustee or director | 1 | $0 |
| STEVEN A KANDARIAN | DIRECTOR Trustee or director | 1 | $0 |
| STEVEN J BURAKOFF MD | DIRECTOR (THRU 10/15/24) Trustee or director | 1 | $0 |
| TODD R GOLUB MD | DIRECTOR Trustee or director | 1 | $0 |
990 for the year ended June 30, 2024: 46 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| YUNG S LIE PHD | PRESIDENT & CEO Officer | 40 | $533,687 | $65,712 |
| CLARE CAHILL | CHIEF ADMINISTRATIVE OFFICER Highest-paid employee | 40 | $245,416 | $40,690 |
| KIMBERLY KUBERT | DIRECTOR OF SPECIAL EVENTS Highest-paid employee | 40 | $205,635 | $47,338 |
| ELYSE HOFFMANN | DIRECTOR OF STRATEGIC PARTNERSHIP Highest-paid employee | 40 | $152,327 | $36,942 |
| MEGHAN MCCURDY | DIR. OF COMMUNICATIONS & MARKETING Highest-paid employee | 40 | $150,319 | $37,914 |
| JOHN SPAIN | DIRECTOR OF DEVELOPMENT OPERATIONS Highest-paid employee | 40 | $134,185 | $28,861 |
| CARLOS L ARTEAGA MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAVID M BEIRNE | VICE CHAIR Trustee or director | 1 | $0 | $0 |
| STEVEN J BURAKOFF MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MELISSA L COHN | DIRECTOR (AS OF 10/30/23) Trustee or director | 1 | $0 | $0 |
| ROBYN COLES | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GARY E ERLBAUM | DIRECTOR Trustee or director | 1 | $0 | $0 |
| BUCK FRENCH | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ELAINE V FUCHS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| LEVI A GARRAWAY MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| RICHARD B GAYNOR MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ERICA EVANS GIOFFRE | DIRECTOR (AS OF 03/06/24) Trustee or director | 1 | $0 | $0 |
| TODD R GOLUB MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAVID A GORDON PHD | DIRECTOR (AS OF 10/30/23) Trustee or director | 1 | $0 | $0 |
| SCOTT GREENSTEIN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| STEVE HAYDEN | DIRECTOR (THRU 10/23/2023) Trustee or director | 1 | $0 | $0 |
| MORANA JOVAN-EMBIRICOS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| STEVEN A KANDARIAN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NOAH KNAUF | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GABRIELLE LAYTON PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GERALD M MARAHALL | DIRECTOR (AS OF 10/30/23) Trustee or director | 1 | $0 | $0 |
| RICHARD W MEIER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN H MYERS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| RICHARD J O'REILLY MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOSEPH PEARLBERG MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| LORI J PIERCE MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ANDREW S RACHLEFF | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ADAM R SCHWARTZ | DIRECTOR (AS OF 10/30/23) Trustee or director | 1 | $0 | $0 |
| MICHAEL V SEIDEN MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KAREN D SEITZ | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NANCY SIMONIAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| AMOOLYA SINGH PHD | DIRECTOR (AS OF 03/06/24) Trustee or director | 1 | $0 | $0 |
| CYNTHIA SULZBERGER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JUDY SWANSON | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETER VAN CAMP | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES WELLS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DEBORAH J COLEMAN | CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| WILLIAM G KAELIN JR MD | VICE CHAIR, SCIENTIFIC PROGRAMS Trustee or director, Officer | 1 | $0 | $0 |
| MICHAEL L GORDON | VICE CHAIR, BOARD DEVELOPMENT Trustee or director, Officer | 1 | $0 | $0 |
| DAVID G MARSHALL | VICE CHAIR, INVESTMENTS & TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| SANFORD W MORHOUSE ESQ | VICE CHAIR, AUDIT & SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
990 for the year ended June 30, 2023: 42 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| YUNG S LIE PHD | PRESIDENT & CEO Officer | 40 | $518,265 | $72,685 |
| CLARE CAHILL | CHIEF ADMINISTRATIVE OFFICER Highest-paid employee | 40 | $225,461 | $33,170 |
| KIMBERLY KUBERT | DIRECTOR OF SPECIAL EVENTS Highest-paid employee | 40 | $188,766 | $32,388 |
| MEGHAN MCCURDY | DIRECTOR OF COMMUNICATIONS & MARKETING Highest-paid employee | 40 | $138,728 | $42,785 |
| JOHN SPAIN | DIRECTOR OF DEVELOPMENT OPERATIONS Highest-paid employee | 40 | $126,093 | $27,720 |
| MELISSA MOORE | DIRECTOR PHILANTHROPY (THRU 8/5/22) Highest-paid employee | 40 | $135,892 | $16,988 |
| DEBORAH J COLEMAN | CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| WILLIAM G KAELIN JR MD | VICE CHAIR, SCIENTIFIC PROGRAMS Trustee or director, Officer | 1 | $0 | $0 |
| MICHAEL L GORDON | VICE CHAIR, BOARD DEVELOPMENT Trustee or director, Officer | 1 | $0 | $0 |
| DAVID G MARSHALL | VICE CHAIR, INVESTMENTS & TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| SANFORD W MORHOUSE ESQ | VICE CHAIR, AUDIT & SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| DAVID M BEIRNE | VICE CHAIR Trustee or director | 1 | $0 | $0 |
| CARLOS L ARTEAGA MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| STEVEN J BURAKOFF MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBYN COLES | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GARY E ERLBAUM | DIRECTOR Trustee or director | 1 | $0 | $0 |
| THOMAS J FAHEY JR MD | DIRECTOR (THRU 7/22/22) Trustee or director | 1 | $0 | $0 |
| BUCK FRENCH | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ELAINE V FUCHS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| LEVI A GARRAWAY MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| RICHARD B GAYNOR MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| TODD R GOLUB MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SCOTT GREENSTEIN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| STEVE HAYDEN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MORANA JOVAN-EMBIRICOS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| STEVEN A KANDARIAN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NOAH KNAUF | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GABRIELLE LAYTON PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| RICHARD W MEIER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN H MYERS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| RICHARD J O'REILLY MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOSEPH PEARLBERG MD PHD | DIRECTOR (AS OF 7/28/22) Trustee or director | 1 | $0 | $0 |
| LORI J PIERCE MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ANDREW S RACHLEFF | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MEGHAN RAVEIS | DIRECTOR (THRU 6/23/23) Trustee or director | 1 | $0 | $0 |
| MICHAEL V SEIDEN MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KAREN D SEITZ | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NANCY SIMONIAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CYNTHIA SULZBERGER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JUDY SWANSON | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETER VAN CAMP | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES WELLS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1 EXCHANGE PLZ STE 302, NEW YORK, NY 10006-3720
- Principal officer (990 for 2024)
- DR YUNG LIE, 55 BROADWAY 302, New York, NY 10006
- Signed the 990
- YUNG S LIE PHD, PRESIDENT & CEO
- Phone
- (212) 455-0532
- Website
- WWW.DAMONRUNYON.ORG
- Return prepared by
- BDO USA
Mission
TO ACCELERATE BREAKTHROUGHS BY PROVIDING TODAY'S BEST YOUNG SCIENTISTS WITH FUNDING TO PURSUE INNOVATIVE CANCER RESEARCH. THE FOUNDATION'S GOALS ARE TO IDENTIFY AND FUND THE BEST AND BRIGHTEST EARLY-CAREER SCIENTISTS IN CANCER RESEARCH; ENABLE THEM TO TAKE RISKS ON BOLD NEW IDEAS; AND ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES INTO NEW WAYS TO PREVENT OR CURE ALL FORMS OF CANCER. ITS INTERNATIONALLY RECOGNIZED AND HIGHLY COMPETITIVE GRANT PROGRAMS ARE DESIGNED TO ACHIEVE THESE GOALS.
Program accomplishments
- FELLOWSHIP AWARDS: SUPPORTS THE TRAINING OF THE BRIGHTEST POSTDOCTORAL SCIENTISTS AS THEY EMBARK UPON THEIR RESEARCH CAREERS. THIS FUNDING ENABLES THEM TO BE TRAINED BY ESTABLISHED INVESTIGATORS IN LEADING RESEARCH LABORATORIES ACROSS THE COUNTRY, WHILE INDEPENDENTLY CONDUCTING LEADING-EDGE SCIENCE THAT WILL BRING NEW UNDERSTANDING AND CURES FOR CANCER.Expenses $8,950,287 · grants $8,076,239
- CLINICAL INVESTIGATOR AWARDS: SUPPORTS EARLY CAREER PHYSICIAN-SCIENTISTS CONDUCTING PATIENT-ORIENTED RESEARCH. THE GOAL OF THIS PROGRAM IS TO INCREASE THE NUMBER OF PHYSICIANS CAPABLE OF MOVING SEAMLESSLY BETWEEN THE LABORATORY AND THE PATIENT'S BEDSIDE IN SEARCH OF BREAKTHROUGH TREATMENTS.Expenses $4,440,990 · grants $4,030,412
- RACHLEFF INNOVATION AWARDS: SUPPORTS THE NEXT GENERATION OF EXCEPTIONALLY CREATIVE THINKERS WITH "HIGH RISK/HIGH REWARD" IDEAS THAT HAVE THE POTENTIAL TO SIGNIFICANTLY IMPACT OUR UNDERSTANDING OF AND/OR APPROACHES TO THE PREVENTION, DIAGNOSIS OR TREATMENT OF CANCER, BUT LACK SUFFICIENT PRELIMINARY DATA TO OBTAIN TRADITIONAL FUNDING.Expenses $3,514,664 · grants $3,194,644
- THE DAMON RUNYON-ST. JUDE PEDIATRIC CANCER RESEARCH FELLOWSHIP AWARD: IN PARTNERSHIP WITH ST. JUDE CHILDREN'S RESEARCH HOSPITAL, THIS AWARD PROVIDES FUNDING TO EARLY CAREER SCIENTISTS CONDUCTING RESEARCH WITH THE POTENTIAL TO SIGNIFICANTLY IMPACT THE PREVENTION, DIAGNOSIS, OR TREATMENT OF ONE OR MORE PEDIATRIC CANCERS.Expenses $2,032,178 · grants $1,826,095
- QUANTITATIVE BIOLOGY FELLOWSHIP AWARDS: THIS AWARD PROGRAM IS DESIGNED TO ENCOURAGE QUANTITATIVE SCIENTISTS (TRAINED IN FIELDS SUCH AS MATHEMATICS, COMPUTER SCIENCE, PHYSICS, ENGINEERING, AND OTHERS) TO PURSUE RESEARCH CAREERS IN COMPUTATIONAL BIOLOGY UNDER THE JOINT MENTORSHIP OF LEADERS IN BOTH COMPUTATIONAL SCIENCE ("DRY LAB") AND CANCER BIOLOGY ("WET LAB"). BY INVESTING IN THIS AREA, DAMON RUNYON WILL BRING ADDITIONAL ATTENTION TO THE IMPORTANCE OF THESE SPECIALLY TRAINED SCIENTISTS FOR MAKING MEANINGFUL PROGRESS IN CANCER BIOLOGY.Expenses $1,267,965 · grants $1,153,426
- PHYSICIAN-SCIENTIST TRAINING AWARDS: SUPPORTS AND ENCOURAGES OUTSTANDING PHYSICIANS TO PURSUE CANCER RESEARCH CAREERS BY PROVIDING THEM WITH THE OPPORTUNITY FOR A PROTECTED RESEARCH TRAINING EXPERIENCE UNDER THE MENTORSHIP OF A HIGHLY QUALIFIED AND GIFTED MENTOR.Expenses $1,267,335 · grants $1,144,849
- DALE F. FREY AWARDS: AWARDS ARE GIVEN TO THE MOST OUTSTANDING FELLOWS COMPLETING THEIR FELLOWSHIP AWARD, IN THE AMOUNT OF $100,000 EACH, TO ACCELERATE THEIR RESEARCH AND CAREERS.Expenses $538,012 · grants $495,240
- SPARK SCHOLARS: PROVIDES OUTSTANDING RECENT COLLEGE GRADUATES WITH THE POTENTIAL TO BECOME SCIENTIFIC LEADERS WITH A FINANCIAL STIPEND, INTENSIVE LABORATORY TRAINING, A NETWORK OF MENTORS AND PEERS, AND OTHER RESOURCES TO SUPPORT THEIR NEXT CAREER STEPS.Expenses $279,698 · grants $249,130
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 13-1933825
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1947
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Health care (E120)
- Assets (IRS master file)
- $170,380,475
- Income (IRS master file)
- $177,565,031
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $54,683,607 | $25,059,618 | $170,380,475 | XML |
| 990 | June 2024 | $19,559,693 | $25,408,684 | $160,511,709 | XML |
| 990 | June 2023 | $15,715,675 | $21,219,216 | $147,680,687 | XML |
| 990 | June 2022 | $14,385,319 | $21,596,927 | $143,543,813 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-1933825).
Questions about CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION
- What is the EIN of CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION?
- The employer identification number (EIN) of CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION is 13-1933825.
- Is CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1947.
- Are donations to CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION?
- The 990 for the year ended June 30, 2025 names DR YUNG LIE.
- Who are the officers and directors of CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION?
- The 990 for the year ended June 30, 2025 lists 47 people; 6 received compensation from the organization, the highest $592,380 (YUNG S LIE PHD, PRESIDENT & CEO).
- How much revenue does CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $54,683,607, expenses of $25,059,618 and total assets of $170,380,475 at year end.
Other nonprofits in NEW YORK
- HEALTHFIRST PHSP INC EIN 13-3783732 · last filed 990 for 2024
- THE NEW YORK AND PRESBYTERIAN HOSPITAL EIN 13-3957095 · last filed 990 for 2024
- NYU LANGONE HOSPITALS EIN 13-3971298 · last filed 990 for 2025
- MEMORIAL SLOAN-KETTERING CANCER CENTER EIN 91-2154267 · last filed 990 for 2024
- METROPLUS HEALTH PLAN INC EIN 13-4115686 · last filed 990 for 2024
- HEALTH INSURANCE PLAN OF GREATER NEW YORK EIN 13-1828429 · last filed 990 for 2024
- MOUNT SINAI HOSPITAL EIN 13-1624096 · last filed 990 for 2024
- VNS CHOICE EIN 13-3951057 · last filed 990 for 2024